A comparative audit of prevalent, incident and interval cancers in the Avon breast screening programme

Annals of the Royal College of Surgeons of England

Volumn 79, Issue 4, 1997, Pages 272-275

  Sylvester, P A ^a   Vipond, M N ^a   Kutt, E ^a   Davies, J D ^b   Webb, A J ^a   Farndon, J R ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Breast screening; Interval cancers

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; EARLY DIAGNOSIS; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL AUDIT; UNITED KINGDOM;

BREAST NEOPLASMS; ENGLAND; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MEDICAL AUDIT; PREVALENCE;

EID: 1842414801     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Forrest APM. Breast Cancer Screening - Report to the Health Ministers of England, Wales, Scotland and Northern Ireland, DHSS, London: HMSO, 1986.
2. Shapiro S, Venet W, Strax P, Venet L. Ten to fourteen year effect of screening for breast cancer mortality. J Natl Cancer Inst 1982: 69: 349.
3. Tabar L, Fagerberg G, Duffy SW, Day NE. The Swedish Two-County Trial of mammographie screening for breast cancer: recent results and calculations of benefit. J Epidemiol Community Health 1989: 43: 107-14.
4. Verbeck ALM, Hendriks JHCL, Holland R, Mravunac M, Sturmans F, Day NE. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen Project, 1975-1981. Lancet 1984: 1: 1222-4.
5. Crisp WJ, Higgs MJ, Cowan WK et al. Screening for breast cancer detects tumours at an earlier biological stage. Br J Surg 1993: 80: 863-5.
6. Nystrom L, Rutqvist LE, Wall S et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993: 341: 973-8.
7. UK Trials of Early Detection of Breast Cancer Group. First results of mortality reduction in the UK Trial of early detection of breast cancer. Lancet 1988: 2: 411-16.
8. Andersson I, Aspergen K, Janzon L, Landberg T, Lindholm K, Lincee F. Mammographic screening and mortality from breast cancer. The Malmo Mammographic Screening Trial. Br Med J 1988: 297: 943-50.
9. Roberts MM, Alexander FE, Anderson TJ et al. The Edinburgh Trial of screening for breast cancer. Mortality results at seven years. Lancet 1990: 335: 241-6.
10. Chamberlain J, Moss SM, Kirkpatrick AE, Michell M, Johns L. National Health Service Breast Screening Programme results for 1991-2. Br Med J 1993: 307: 353-6.
11. Tabar L, Fagerburg G, Day NE, Holmberg L. What is the optimum interval between mammographie screening examinations? An analysis based on the latest results of the Swedish Two-County Breast Cancer Screening Trial. Br J Cancer 1987: 55: 547-51.
12. Peeters PHM, Verbeck ALM, Hendriks JHCL, Holland R, Mravunac M, Vooijs GP. The occurrence of interval cancers in the Nijmegen screening programme. Er J Cancer 1989: 59: 929-32.
13. Frissel J, Eklund G, Hellstrom L, Somell A. Analysis of interval breast carcinomas in a randomised screening trial in Stockholm. Breast Cancer Res Treat 1987: 9: 219-25.
14. Woodman CBJ, Threlfall AG, Boggis CRM, Prior P. Is the three year breast screening interval too long? Occurrence of interval cancers in the NHS Breast Screening Programme's North Western region. Br Med J 1995: 310: 224-6.
15. Roberts MM. Breast screening: time for a rethink? Br Med J 1989: 299: 1153-5.
16. Dixon JM. Screening for breast cancer. Br J Surg 1993: 80: 141-2.
17. Field S, Michell MJ, Wallis MGW, Wilson ARM. What should be done about interval breast cancers? Br Med J 1995: 310: 203-4.
18. Thomas BA. Population breast cancer screening: theory, practice and service implications. Lancet 1995: 345: 205-7.
19. Bird DL, Fox JN, Ashley S, Imrie MJ. Results of the first year of breast cancer screening in a district hospital. Br J Surg 1992: 79: 922-4.
20. Campbell I, Royle G, Coddington R et al. Management of screen-detected breast cancer: audit of the first 100 cases in the Southampton and Salisbury breast screening programme. Ann R Coll Surg Engl 1993: 75: 13-17.
21. Andersson I, Hildell J, Muhlow A, Petterson H. Number of projections in mammography: influence on detection of breast disease. AJR 1978: 130: 349-51.
22. Bassett LW, Bunnell DH, Jahanshahi R, Gold RH, Arndt RD, Linsman J. Breast cancer detection: one versus two views. Radiology 1987: 165: 95-7.
23. Wald NJ, Murphy P, Major P, Parkes C, Townsend J, Frost C. UKCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. Br Med J 1995: 311: 1189-93.
24. Anttinen I, Pamilo M, Soiva M, Roiha M. Double reading of mammography screening films-one radiologist or two? Clin Radiol 1993: 48: 414-21.
25. Anderson ED, Muir BB, Walsh JS, Kirkpatrick AE. The efficacy of double reading mammograms in breast screening. Clin Radiol 1994: 49: 248-51.
26. Van Dijck JAAM, Verbeeck ALM, Hendriks JHCL, Holland R. The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen detected cancers. Cancer 1993: 72: 1933-8.
27. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish Two-County program of mammographic screening for breast cancer. Radiol Clin North Am 1992: 30: 187-210.
28. Quinn M, Allen E. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. Br Med J 1995: 311: 1391-5.
29. Wright CJ, Mueller CB. Screening mammography and public health policy: the need for perspective. Lancet 1995: 346: 29-32.
30. Baum M. Screening for breast cancer, time to think - and stop ? Lancet 1995: 346: 436-7.